MYRIAD GENETICS INC 8-K

What Happened
Myriad Genetics, Inc. (MYGN) filed a Form 8-K on February 23, 2026 (Item 2.02) to announce its financial results for the three months ended December 31, 2025. The company's earnings release for that quarter is attached to the filing as Exhibit 99.1 and incorporated by reference. The filing also includes a standard cautionary note about forward-looking statements.

Key Details

• Announcement date: February 23, 2026 (Form 8-K filed).
• Reporting period: three months ended December 31, 2025.
• Earnings release attached as Exhibit 99.1 to the Form 8-K.
• Filing includes a forward-looking statements caution and an Inline XBRL cover page (Exhibit 104).

Why It Matters
This 8-K signals that Myriad has published its quarterly earnings information — the release will contain the specific revenue, profit/loss, and other operating metrics investors use to evaluate short-term performance. The attached earnings release (Exhibit 99.1) is the primary source for detailed figures and management commentary; investors should review it to see results and any updated outlook. The forward-looking statements caution reminds investors that any guidance or projections in the release are subject to risks and uncertainties.